[go: up one dir, main page]

TN2010000431A1 - New formulations, tablets comprising such formulations, their use and process for their preparation - Google Patents

New formulations, tablets comprising such formulations, their use and process for their preparation

Info

Publication number
TN2010000431A1
TN2010000431A1 TNP2010000431A TN2010000431A TN2010000431A1 TN 2010000431 A1 TN2010000431 A1 TN 2010000431A1 TN P2010000431 A TNP2010000431 A TN P2010000431A TN 2010000431 A TN2010000431 A TN 2010000431A TN 2010000431 A1 TN2010000431 A1 TN 2010000431A1
Authority
TN
Tunisia
Prior art keywords
formulations
preparation
tablets
new
drug
Prior art date
Application number
TNP2010000431A
Other languages
French (fr)
Inventor
Thomas Friedl
Michael Braun
Kenji Egusa
Hikaru Fujita
Megum Maruyama
Takaaki Nishioka
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/053978 external-priority patent/WO2009121945A2/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2010000431A1 publication Critical patent/TN2010000431A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
TNP2010000431A 2009-04-02 2010-09-21 New formulations, tablets comprising such formulations, their use and process for their preparation TN2010000431A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/053978 WO2009121945A2 (en) 2008-04-03 2009-04-02 New formulations, tablets comprising such formulations, their use and process for their preparation

Publications (1)

Publication Number Publication Date
TN2010000431A1 true TN2010000431A1 (en) 2011-12-29

Family

ID=55024553

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000431A TN2010000431A1 (en) 2009-04-02 2010-09-21 New formulations, tablets comprising such formulations, their use and process for their preparation

Country Status (1)

Country Link
TN (1) TN2010000431A1 (en)

Similar Documents

Publication Publication Date Title
MX351232B (en) Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation.
UA106634C2 (en) Solid pharmaceutical dosage form
PH12012502161A1 (en) Pharmaceutical formulations comprising pioglitazone and linagliptin
PH12013501842A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
PH12014501984A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
MY189427A (en) Pyrazolyl quinoxaline kinase inhibitors
MX338712B (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof.
GB201118656D0 (en) New compounds
IN2014MN00986A (en)
TN2012000515A1 (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
IN2012DN01435A (en)
PH12012500622A1 (en) Compounds for the treatment of dyslipidemia and related diseases
MX2014002395A (en) Novel rock kinase inhibitors.
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
PL2081910T3 (en) Novel compounds
PH12012502083A1 (en) Manufacturing of active-free granules and tablets comprising the same
TN2010000431A1 (en) New formulations, tablets comprising such formulations, their use and process for their preparation
TH149179A (en) Pharmaceutical compositions, pharmaceutical forms, processes for preparing such compositions and forms, methods of treatment and use of such compositions and forms.
GB201111427D0 (en) Novel bisindolylmaleimides, pan-pkc inhibitors
TH110692A (en) New formulation, tablets containing the above formulation, use of that formulation And the process for preparing the formula